Veresca™ FOXC1 IHC Breast Cancer Test and other Veresca™ products under development may be covered by one or more of the following United States patents; other U.S. patents and/or their international equivalents may also apply or be pending.  To the extent a name, product feature, design or logo does not appear on the following list, such omission does not constitute a waiver of any and all intellectual property rights that Onconostic Technologies, Inc. and 3N Diagnostics Ltd. have established in  any of its products, features, service names, product names or logos.